Trial
NCT00609765
Avastin, Fluorouracil, Doxorubicin and Streptozocin in Locally Advanced and Metastatic Pancreatic Endocrine Tumors
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Collaborators
Genentech, Inc.
Condition
Pancreatic Cancer
Intervention
Avastin
Why stopped
Development of new chemotherapy standard of care for treatment rendered the trial obsolete.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-03-23